Published in Parkinsons Dis on December 17, 2015
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67
The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci (2008) 29.64
The fusiform face area: a module in human extrastriate cortex specialized for face perception. J Neurosci (1997) 22.73
Deep brain stimulation for treatment-resistant depression. Neuron (2005) 12.39
Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry (2007) 9.08
Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry (1999) 7.87
Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci (1997) 6.75
Response and habituation of the human amygdala during visual processing of facial expression. Neuron (1996) 5.93
A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry (2008) 5.06
Depression and Parkinson's disease: a review. Am J Psychiatry (1992) 4.36
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A (2003) 4.21
Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull (2003) 4.08
The default mode network and self-referential processes in depression. Proc Natl Acad Sci U S A (2009) 4.05
Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry (2000) 4.03
Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry (2011) 3.78
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev (2005) 3.60
A method for obtaining 3-dimensional facial expressions and its standardization for use in neurocognitive studies. J Neurosci Methods (2002) 3.25
Face-specific processing in the human fusiform gyrus. J Cogn Neurosci (1997) 3.18
Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci (2011) 3.10
Neural responses to facial and vocal expressions of fear and disgust. Proc Biol Sci (1998) 2.93
Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry (2003) 2.69
Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci (1999) 2.52
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain (2005) 2.34
Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci (2005) 2.04
Cognitive control and brain resources in major depression: an fMRI study using the n-back task. Neuroimage (2005) 2.02
Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol (2002) 1.87
Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain (2002) 1.75
Neural substrates of facial emotion processing using fMRI. Brain Res Cogn Brain Res (2001) 1.61
Dysfunction of the default mode network in Parkinson disease: a functional magnetic resonance imaging study. Arch Neurol (2009) 1.49
Medial cortex activity, self-reflection and depression. Soc Cogn Affect Neurosci (2009) 1.48
Reciprocal modulation and attenuation in the prefrontal cortex: an fMRI study on emotional-cognitive interaction. Hum Brain Mapp (2004) 1.45
Medial prefrontal cortex and the self in major depression. J Affect Disord (2010) 1.43
Facial discrimination and emotional recognition in schizophrenia and affective disorders. Arch Gen Psychiatry (1986) 1.41
Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry (1994) 1.40
Differences between depressed and nondepressed individuals in the recognition of and response to facial emotional cues. J Abnorm Psychol (1993) 1.40
Increased self-focus in major depressive disorder is related to neural abnormalities in subcortical-cortical midline structures. Hum Brain Mapp (2009) 1.40
The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev Neurosci (2006) 1.38
Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J Neurosci (2002) 1.38
Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies. Neurosci Biobehav Rev (2013) 1.32
Antidepressants normalize the default mode network in patients with dysthymia. JAMA Psychiatry (2013) 1.25
The 'resting-state hypothesis' of major depressive disorder-a translational subcortical-cortical framework for a system disorder. Neurosci Biobehav Rev (2010) 1.23
Facial expression recognition in people with medicated and unmedicated Parkinson's disease. Neuropsychologia (2003) 1.23
Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychologia (2006) 1.15
Dopaminergic suppression of brain deactivation responses during sequence learning. J Neurosci (2008) 1.15
Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology (1992) 1.14
Emotional facial imagery, perception, and expression in Parkinson's disease. Neurology (1995) 1.14
Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology (1986) 1.14
Evidence for an apparent sensory speech disorder in Parkinson's disease. J Neurol Neurosurg Psychiatry (1984) 1.08
Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry (2002) 1.06
Dopaminergic modulation of the default mode network in Parkinson's disease. Eur Neuropsychopharmacol (2010) 1.06
Depression in Parkinson's disease. A positron emission study. Br J Psychiatry (1994) 1.05
Depression and cognitive impairment in Parkinson's disease. Brain (1989) 1.01
Low activity allele of catechol-o-methyltransferase gene and Japanese unipolar depression. Neuroreport (1998) 1.00
The functional Val158Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study. J Affect Disord (2010) 0.98
Emotional dysfunction in Parkinson's disease. Behav Neurol (2011) 0.95
Levodopa treatment may benefit or impair "frontal" function in Parkinson's disease. Lancet (1986) 0.95
Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus. Neuroimage (2009) 0.94
Major depression is associated with impaired processing of emotion in music as well as in facial and vocal stimuli. J Affect Disord (2011) 0.92
Intact recognition of facial emotion in Parkinson's disease. Neuropsychology (1998) 0.89
The effects of right and left hemiparkinsonism on prosody. Brain Lang (1989) 0.88
High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease. Neurosci Lett (1997) 0.88
Catechol-O-methyltransferase and Parkinson's disease. Acta Med Okayama (2002) 0.85
Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population. BMC Neurol (2011) 0.83
Discrimination of facial expressions of emotion by depressed subjects. Genet Soc Gen Psychol Monogr (1989) 0.80
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease. Mov Disord (2005) 0.80
Dopaminergic modulation of memory and affective processing in Parkinson depression. Psychiatry Res (2013) 0.78